About
Wild Biotech is developing an AI-powered drug-discovery platform that can jumpstart the creation of new medicines for a vast array of illnesses. Wild Biotech has created an annotated metagenomic database of wild animal microbiota on the planet. It has done so using a process called "de novo metagenome assembly," employing artificial intelligence to organize and analyze gut microbes based on known associations with factors such as the animals' diets, activity, and lifespans. Wild Biotech employs an end-to-end process that goes from field exploration and discovery all the way to drug development and clinical trials. The company tackled inflammatory, immune, and gastrointestinal diseases as its first therapeutic challenges and is currently in the preclinical stage with several lead compounds.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Wild Biotech's primary focus in drug discovery?
- Wild Biotech focuses on microbiome-derived drug discovery and development, utilizing an AI-powered platform to create new medicines for various illnesses.
- When was Wild Biotech founded?
- Wild Biotech was founded in April 2019.
- Where is Wild Biotech's headquarters located?
- Wild Biotech's headquarters is located in Rehovot, Israel, at HaMada Street 8.
- Does Wild Biotech have any other offices?
- Yes, Wild Biotech has an office in Palo Alto, California, USA, at 616 Ramona St.
- What is Wild Biotech's current stage of development?
- Wild Biotech is currently in the Seed stage of development.
- Which investors participated in Wild Biotech's undisclosed funding round in June 2019?
- In June 2019, Wild Biotech received funding from investors including Marius Nacht and Tech.bio.
- What therapeutic areas is Wild Biotech initially targeting?
- Wild Biotech is initially tackling inflammatory, immune, and gastrointestinal diseases, with several lead compounds currently in the preclinical stage.
- How many employees does Wild Biotech currently have?
- Wild Biotech currently has between 1 and 10 employees.
- What is the core technology behind Wild Biotech's platform?
- Wild Biotech's platform uses artificial intelligence for de novo metagenome assembly to organize and analyze gut microbes from wild animal microbiota, creating an annotated metagenomic database.